- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/96 - Two oxygen atoms
Patent holdings for IPC class C07D 239/96
Total number of patents in this class: 136
10-year publication summary
|
11
|
13
|
5
|
4
|
8
|
7
|
13
|
8
|
5
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| IMPACT Therapeutics, Inc. | 35 |
10 |
| Shandong Cynda Chemical Co., Ltd. | 11 |
4 |
| Takeda Pharmaceutical Company Limited | 2703 |
3 |
| EA Pharma Co., Ltd. | 88 |
3 |
| Ludwig Institute for Cancer Research Ltd | 189 |
3 |
| Omeros Corporation | 306 |
3 |
| Technion Research & Development Foundation Ltd. | 1215 |
3 |
| Impact Therapeutics (Shanghai), Inc | 49 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 763 |
2 |
| Ajinomoto Co., Inc. | 2291 |
2 |
| Consejo Superior de Investigaciones Cientificas | 866 |
2 |
| Emory University | 1625 |
2 |
| Gilead Sciences, Inc. | 2041 |
2 |
| Ideaya Biosciences, Inc. | 124 |
2 |
| Shin Poong Pharmaceutical Co., Ltd. | 39 |
2 |
| Shionogi & Co., Ltd. | 850 |
2 |
| Southern Research Institute | 210 |
2 |
| Sutro Biopharma, Inc. | 169 |
2 |
| Rambam Med-Tech Ltd. | 86 |
2 |
| Sanofi | 4081 |
2 |
| Other owners | 80 |